Bioject Medical Technologies Inc. announced unaudited consolidated financial results for the third quarter and ended September 30, 2009. For the quarter ended September 30, 2009, the company reported revenues of $1.5 million, compared to $1.7 million reported in the comparable year ago quarter. The company reported a third quarter 2009 operating loss of $210,000, compared to an operating loss of $525,000 in the prior year period, a 60% decrease. Included in the current quarter operating loss of $210,000 is $228,000 of non-cash charges comprised of non-cash compensation expense related to the fair value of stock-based awards, warrants and stock funding of $65,000 and depreciation and amortization of $163,000. The company reported a third quarter 2009 net loss allocable to common shareholders of $187,000, compared to net loss allocable to common shareholders of $1.1 million in the comparable year-ago quarter. Basic and diluted net loss per common share for the quarter ended September 30, 2009 were $0.01 per share, compared to a net loss of $0.07 per share for the same period last year. Loss from operations before preferred stock dividend was $174,000 against $1,040,000 for the comparable period last year For the nine months ended September 30, 2009, the company reported a net loss allocable to common shareholders of $737,000 on revenues of $5.2 million. This compares to a net loss allocable to common shareholders of $2.8 million on revenues of $5.1 million for the same period last year. Basic and diluted net loss per share for the nine months ended September 30, 2009 were $0.04 per share compared to a net loss of $0.18 per share for the comparable period last year. Operating loss was $494,000 and loss from operations before preferred stock dividend was $700,000 on total revenue of $5,195,000 against operating loss of $2,014,000 and loss from operations before preferred stock dividend of $2,608,000 on total revenue of $5,114 ,000 for the comparable period last year.

Bioject Medical Technologies Inc., Q3 2009 Earnings Call, Nov-05 2009

On August 7, 2009, Mr. Joseph F. Bohan III notified Bioject Medical Technologies Inc. that he would not be standing for re-election at the company’s 2009 Annual Meeting. Mr. Bohan will remain a member of the company’s board of directors until the date of its 2009 Annual Meeting.